1. US pharmaceutical company Johnson & Johnson (J&J) Pvt Ltd has agreed to pay 25 lakhs to 67 patients affected by its faulty acetabular surface replacement (ASR) hip implants. Earlier,in May Delhi High Court directed it to pay ₹25 lakh each to 4 patients affected by its faulty hip implants.
2. Central Drugs Standard Control Organization (CDSCO) had ordered the company to pay compensation to these patients, following the recommendation of the central expert committee.
3. Government formed R K Arya committee to devise a formula to determine the quantum of compensation based on the percentage of disability, age factor and risk factor. In 2017 the government formed another panel headed by Dr Arun Agarwal, to suggest compensation for each patient.
4.CDSCO is the national regulatory body for Indian pharmaceuticals and medical devices .